
Oculogica Inc Profile last edited on: 3/14/2022
CAGE: 6YZ18
UEI: XE6ZBMCJ9LH5
Business Identifier: Eye-tracking based neurodiagnostics with primary focus on concussion Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 12
County: New York
Congr. District: 12
County: New York
Public Profile
Oculogica Inc. is a neurodiagnostic company developing patent-pending technology to detect brain abnormalities such as concussion and traumatic brain injury (TBI). The company's proprietary EyeBox technology* works by detecting patterns of abnormal eye movements and unlocks the potential to not only localize brain injury but also to assess its severity. With collaborators, the firm was founded by a neurosurgeon and research scientist. The firm's technology could transform traumatic brain injury diagnosis, bring personalized medicine to concussion diagnosis and treatment, and, most likely, for the military, on the playing field and court as well as in the hospital setting for those having inmany other ways incurred blows to their head, could improve outcomes for those millions of people who annually suffer TBI and concussion.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
20-24Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2018 | 1 | NIH | $553,162 | |
Project Title: A Software Tool for Objective Identification of Concussion-Related Vision Disorders Using a Novel Eye-Tracking Device |
Key People / Management
Rosina Samadani -- CEO and Board of Advisors
Viridiana Juarez -- Analyst
Christina Master
Robert Ritlop -- Founder
Hannah Rosenfeld -- Clinical Operations Manager
Uzma Samadani -- Founder
Daniel O Sanderson -- Principal Engineer
Joel D Sanderson -- Developer
Mark Stenoien -- VP of Regulatory Affairs
Viridiana Juarez -- Analyst
Christina Master
Robert Ritlop -- Founder
Hannah Rosenfeld -- Clinical Operations Manager
Uzma Samadani -- Founder
Daniel O Sanderson -- Principal Engineer
Joel D Sanderson -- Developer
Mark Stenoien -- VP of Regulatory Affairs
Company News
Apr
26
2018
|
Looking concussion in the eye |